FLAI induction regimen in elderly patients with acute myeloid leukemia

Prognosis of elderly acute myeloid leukemia (AML) patients remains dismal with less than 15–20% of long-term survivors. Though challenged by hypomethylating agents (HMA), intensive chemotherapy (IC...